CBIZ (CBZ) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual Meeting scheduled for May 15, 2025, to elect three directors, ratify KPMG LLP as auditor, and hold a say-on-pay vote.
Proxy materials distributed via internet and mail; shareholders encouraged to vote by proxy or in person.
Board consists of ten members, with a mix of long-serving and newly appointed directors, including recent addition Kathy A. Raffa following the Marcum acquisition.
Shareholder proposals for the 2026 meeting must be submitted by December 4, 2025.
Voting matters and shareholder proposals
Proposals include election of three directors for terms expiring in 2028, ratification of KPMG LLP as auditor, and a non-binding advisory vote on executive compensation.
Majority vote required for approval; abstentions count as votes against, broker non-votes have no effect.
No shareholder proposals were received for inclusion in this proxy statement.
Board of directors and corporate governance
Board divided into three classes; current nominees are Rick L. Burdick, Jerome P. Grisko, Jr., and Kathy A. Raffa.
Board committees: Audit, Compensation and Human Capital, Nominating and Governance—all members are independent.
Board leadership is separated between an independent Chair and CEO.
Board and committees conducted regular and special meetings, with high attendance.
Board self-assessment and performance reviews are conducted annually.
Latest events from CBIZ
- Revenue up 52% to $2.8B in 2025, with 2026 targeting 2–5% growth and higher free cash flow.CBZ
Q4 202525 Feb 2026 - Q2 revenue up 5.4%; $2.3B Marcum deal to close Q4, creating a top-7 U.S. accounting provider.CBZ
Q2 20242 Feb 2026 - Balanced organic and acquisition-driven growth, high retention, and margin expansion drive outperformance.CBZ
The 44th Annual William Blair Growth Stock Conference31 Jan 2026 - Q3 adjusted EPS up 27.3% and Marcum acquisition completed, boosting scale and leverage.CBZ
Q3 202418 Jan 2026 - Acquisition of Marcum creates a top-7 firm, boosting scale, recurring revenue, and growth prospects.CBZ
Sidoti Small-Cap Virtual Investor Conference11 Jan 2026 - Q1 2025 revenue up 69.5% to $838M, adjusted EBITDA doubled, Marcum integration on track.CBZ
Q1 202525 Dec 2025 - 2025 guidance: $2.90–$2.95B revenue, $3.60–$3.65 adjusted EPS, $450M–$456M EBITDA.CBZ
Q4 202421 Dec 2025 - Shareholders to vote on $2.3B Marcum acquisition, with major stock issuance and board changes.CBZ
Proxy Filing1 Dec 2025 - Shareholders to vote on a $2.3B merger with Marcum LLP, adding 22% new shares and board representation.CBZ
Proxy Filing1 Dec 2025